RxDoctor Payments Data

Jennifer Blanks

Family · Gulf Breeze, FLNPI 1518634302

Payments from drug & device makers

$4,857in general payments, 2019–2025

Across 262 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AbbVie$1K
  • Novartis$853
  • UCB, Inc.$751
  • AstraZeneca$442
  • Johnson & Johnson$392
  • plus $186 from 2 others

What the payments were for

  • Food & beverage$4,66796%
  • Education$1904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)55$1,121
AbbVie54$1,113
Novartis69$853
UCB, Inc.49$751
AstraZeneca13$442
Johnson & Johnson12$392
Lilly USA, LLC9$162
Sandoz1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,857 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Other family in Gulf Breeze

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →